Lysogene announced that it will not be able to release its 2022 financial results and its 2022 Universal Registration Document before the April 30, 2023 deadline. The Commercial Court of Nanterre should rule on the next steps regarding the reorganization proceedings and on the possible opening of a judicial liquidation proceedings in the coming weeks. In this context, the listing of Lysogene's shares will remain suspended.